Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Sarcoma
•
Pediatric Oncology
What is your typical surveillance imaging for a pediatric patient with history of treated sarcoma off therapy?
Related Questions
How would you approach the prevention of irinotecan-induced diarrhea in a patient who previously experienced a diffuse rash with cefixime?
How do you approach adjuvant therapy for resected Stage I Ewing sarcoma of the kidney?
How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?
How do you consider SBRT relative to other emerging therapies for pediatric sarcomas, such as proton therapy or immunotherapy, in terms of efficacy and safety?
What is your approach to patients/parents seeking alternative or complementary treatment in pediatric oncology patients?
What workup do you complete for a teenage patient presenting with an incidentally discovered adrenal mass?
How do you incorporate psychological care into the surveillance and treatment of a pediatric patient found to have a cancer predisposition syndrome?
If a pediatric patient has a prior history of cancer-associated thrombosis while receiving active treatment, can they be on estrogen-containing OCPs in the future?
Do you routinely use thrombopoietin receptor agonists (like romiplostim) to address chemotherapy-induced thrombocytopenia in solid tumor pediatric oncology patients?
Which oral chemotherapy regimen do you use in relapsed fusion positive rhabdomyosarcoma?
